Analysts React: Trump Signs Executive Order to Reschedule Cannabis
Analysts discuss the implications of President Trump’s order to reschedule cannabis and its impact on research and investment.
After President Trump signed an executive order directing agencies to reschedule cannabis, analysts weighed in on what the shift means for the industry.The Investing News Network notes that rescheduling to Schedule III could open doors for scientific research and allow medical providers to prescribe cannabis products. Analysts highlighted that while it does not legalize recreational cannabis federally, the move could attract new investment and reduce tax burdens for operators.The article also discusses potential challenges and the need for further legislative clarity.
Read the full article here: https://investingnews.com/analysts-react-trump-reschedule-cannabis/
